Related Experiment Videos
Non-Q-wave infarction: diagnosis, prognosis, and treatment
1University of California, San Francisco, School of Medicine.
Insights
Patients with non-Q-wave myocardial infarction face higher reinfarction risks. Early intervention with diltiazem and considering angiography for high-risk individuals can improve outcomes.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Internal Medicine
Background:
- Non-Q-wave myocardial infarction (NQMI) represents an incomplete cardiac event with significant reinfarction potential.
- Prognosis in NQMI is directly linked to the extent of viable myocardium at risk.
- NQMI patients exhibit a higher incidence of reinfarction compared to Q-wave myocardial infarction (QMI) patients.
Purpose of the Study:
- To highlight the prognostic implications of NQMI.
- To identify high-risk patient subgroups within NQMI.
- To discuss therapeutic strategies, including diltiazem and revascularization, for managing NQMI.
Main Methods:
- Review of existing evidence on NQMI prognosis and management.
- Identification of clinical and diagnostic markers of ongoing myocardial ischemia.
- Evaluation of the role of pharmacological and interventional treatments.
Main Results:
- Diltiazem demonstrates potential in preventing early reinfarction post-NQMI.
- Persistent myocardial ischemia (angina, ST depression, perfusion defects) indicates greatest risk.
- Reduced ventricular function exacerbates risk in NQMI patients.
Conclusions:
- NQMI patients require careful risk stratification.
- Patients with ongoing ischemia and/or reduced ventricular function are candidates for angiography and revascularization.
- Timely intervention is crucial for improving outcomes in high-risk NQMI patients.
Abstract:
The patient with a non-Q-wave myocardial infarction should be considered as having an uncompleted myocardial infarction. The ultimate prognosis in this patient depends upon the amount of viable myocardium still at risk. These patients have a higher incidence of reinfarction than those who had a Q-wave infarction. There is evidence that diltiazem after a non-Q-wave infarction can prevent early reinfarction. It is evident that those patients who continue to have myocardial ischemia, manifested by continued angina, ischemia, ST depression, or thallium 201 perfusion defects on exercise, especially if they already have reduced ventricular function, are at the greatest risk. These are the patients who should be considered for angiography and revascularization.